期刊文献+

钛合金颗粒对成骨细胞骨保护素基因表达的影响 被引量:4

Effects of titanium alloy particle on the expression of OPG in human osteoblasts in vitro
原文传递
导出
摘要 目的研究钛合金颗粒对体外培养条件下的成骨细胞骨保护素(OPG)基因表达的影响,探讨人工关节假体松动中磨损颗粒导致的骨溶解机制。方法分别将不同浓度的钛合金颗粒(1、0.1、0.01 mg/mL)与第3~5代成骨细胞共同培养3、6、9d,用RT-PCR方法半定量测定OPG基因mRNA的表达。结果不同浓度的钛合金颗粒均抑制成骨细胞OPG基因表达,各组与空白对照组比较差异有显著性意义(P<0.01);存在一定的剂量、时间-效应关系,随时间延长,钛合金颗粒对OPG基因作用逐渐降低。结论铁合金颗粒使成骨细胞OPG基因表达下降,使破骨细胞分化、活化功能增强,这可能是导致假体松动的骨溶解机制之一。 Objective To study the effects of particulate titanium alloy on expression of osteoprotegerin (OPG) gene in human osteoblasts in vitro so as to understand the mechanism of the periprosthetic osteolysis by wear debris during aseptic loosening. Methods Human bone marrow stromal cells (hBMSCs) were obtained and induced to differentiate and proliferate into osteoblasts which were identified by alkaline phosphatase dye. The 3-5th generations of human osteoblasts were cultured for three, six, and nine days after different concentrations of particulate titanium alloy (1 mg/mL, 0. 1 mg/mL, 0. 01 mg/mL) were added into the medium. The OPG gene expression was quantified by RT-PCR. Results Most of the osteoblasts derived from hBMSCs had the stable growth feature and osteogenetic capability, and the alkaline phosphatase dye results were positive. All the different concentrations of titanium particles suppressed OPG gene expression in osteoblasts and all the experimental groups had significant differences from the control group( P 〈 0. 01 ) . Titanium particles of concentrations from 1 mg/mL to 0.01mg/mL showed inhibition on the expression of OPG in osteoblasts in a dose- and time- effective dependent manner. But the inhibitory effects of particles on the gene expression decreased gradually over a protracted period of time. Conclusion Titanium alloy particles decrease expression of OPG gene in human osteoblasts, and this may contribute to the differentiation of osteoclasts which may lead to the periprosthetic osteolysis.
作者 徐炜 董启榕
出处 《中华创伤骨科杂志》 CAS CSCD 2006年第6期562-565,共4页 Chinese Journal of Orthopaedic Trauma
基金 卫生部科学研究基金(WKJ2004-2-009)
关键词 钛合金颗粒 成骨细胞 骨保护素 Titanium alloy particle Osteoblast Osteoprotegerin ( OPG )
  • 相关文献

参考文献11

  • 1Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res, 1988, 254: 317-330.
  • 2李文毅,陈艺新,尹培荣,陈雄德.磨损颗粒与人工关节无菌性松动[J].国外医学(生物医学工程分册),1999,22(5):293-298. 被引量:1
  • 3Dean DD, Schwartz Z, Lin Y, et al. The effect of ultra-high molecular weight polyethylene wear debris on MG63 osteosarcoma cells in vitro. J Bone Joint Surg(Am), 1999, 81:452-461.
  • 4Vermes C, Roebuck KA, Chandrasekaran R, et al. Particulate wear debris activates protein tyrosine kinases and nuclear factorkappa B, which down-regulates type Ⅰ collagen synthesis in human osteoblasts. J Bone Miner Res, 2000, 15: 1756-1765.
  • 5Nadim JH, Csaba V, Carlo M, et al. Concentration and composition-dependent effect of metal ions on human MG-63 osteoblasts. J Bone Joint Surg(Am), 2002, 84: 420-424.
  • 6刘继中,纪宗玲,陈苏民.OPG/RANKL/RANK系统与骨破坏性疾病[J].生物工程学报,2003,19(6):655-660. 被引量:55
  • 7Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin (OPG)ligand is a cytokine that regulate osteoclast differentiation and activation. Cell, 1998, 93: 165-176.
  • 8Itonaga I, Sabokbar A, Murray DW, et al. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. Ann Rheum Dis,2000, 59: 26-31.
  • 9Granchi D, Amato I, Battistelli L, et al. Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials, 2005, 26: 2371-2379.
  • 10Kim KJ, Itob T, Takagj M, et al. Mouse osteoclast formation induced by joint fluid from failed total hip arthroplasty is inhibited by OPG. Trans Othrop Res Soc, 2002, 37: 218-231.

二级参考文献47

  • 1Simonet W S, Lacey D L, Dunstan C R et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89(2):309-319
  • 2Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology,1998,139(3):1329-1337
  • 3Tan K B, H arrop J, Reddy M et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene, 1997, 204:35-46
  • 4Kwon BS, Wang S, Udagawa N et al. TR1, a new member of the tumor necrosis factor receptor family,induces fibroblast proliferation and inhibits osteoclastogenesisand bone resorption. FASEB, 1998, 12: 845-854
  • 5Yun T J, Chaudhary P M, Shu G L et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. Journal of Immunology. 1998, 161: 6113-6121
  • 6Yamaguchi K, Kinosaki M, Goto M et al. Characterization of structural domains of human osteoclastogenesis inhibitory factor. J Biol Chem, 1998, 273(9):5117-5123
  • 7Tomoyasu A, Goto M, Fujise N et al. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factors. Biochem Biophys Res Com, 1998, 245:382-387
  • 8Tsuda E, Goto M, Mochizuki S I et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochemical and Biophysical Research Communications,1997, 234:137-142
  • 9Bucay N, Sarosi I, Dunstan C R et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev,1998,12:1260-1268
  • 10Malyankar U M, Scatena M, Suchland K L et al. Osteoprotegerin is an αv β3-induced, NF-κ B-dependent survival factor for endothelial cells. J Biol Chem, 2000, 275:20959-20962

共引文献54

同被引文献68

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部